Name: Neuroscience 2023
Start: 2023-02-09
End: 2023-02-11
Location: France

Conference Information

welcome Message

Pulsus Group

Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India has acquired Andrew John Publishing and openaccessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.

Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies ,organizations and scientific societies also from different countries through international CME/CPD accredited conferences and meetings.

Pulsus Group is a Medical publisher that adheres to stringent peer-review procedure with a view to set an example in promoting standard medical research with integrity. Pulsus Group takes pride in getting the endorsements of prestigious associations and societies like Canadian medical societies. As an ardent supporter of medical publishing, Pulsus Group closely associates with the Canadian and other international medical research associations. It publishes a wide range of medical journals that focus on medical specialties like cardiology, Integrative Medicine, Surgery and Reproductive Medicine.Pulsus group is closely associated with globally renowned academic and research societies like Canadian Society of Plastic Surgeons, Canadian Society for Aesthetic Plastic Surgery, Groupe pour l'Avancementde la Microchirurgie Canada, Canadian Society for Surgery of the Hand and also scientific societies like Material Science, Physics, Chemistry, food research associations. It publishes a wide range of journals.

Market Analysis

The global Neurology market is forecast to grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a CAGR (compound annual growth rate) of 3.5% during this timeline. On the other hand, the global neurological biomarkers market was valued at approximately $6.1 billion in 2021. Analysts expect it to grow at a CAGR of 12.9% from 2021 to 2028. Neurological disorders comprise a large part of the population. that ranges universally from epilepsy to Alzheimer's disease and from stroke to headache. As assessed by the WHO, about 6.8 million people die each year due to neurological disorders. The economic cost of neurological disorders was estimated at 139 billion euros in 2007 in Europe.

The huge rise of the global neurological devices market shows the real example of stroke, acute and chronic diseases like epilepsy, Alzheimer's, Parkinson's, Huntington's, movement disorders, ataxia, cerebrovascular disease, multiple sclerosis, etc. An estimated 50 million US people are affected by such neurological disorders that eventually led to expensive treatment methods. Analysts think that in 2019, it would reach $13.6 billion by the current growth which will be discussed in Neuroscience 2023 for the Neurology marketing device.

As the WHO has previously stated, nearly 14% of individuals were affected by any neurological disorder in 2020. The current estimate is that as of now, 50 million people have neurodegenerative diseases and analysts have calculated that this would increase to 115 million by 2050. Globally now, according to the UN report, nearly 1 in 6 of the world's population is affected by a neurological disorder with around 6.8 million people dying annually from the diseases.

There are over 600 known neurological disorders that severely affect the human nervous and muscular systems. Still, for many of the diseases, the treatment options are minimal and therefore the ongoing research should be discussed in Neuroscience 2023. As per statistics, fifty million people are observed to suffer from epilepsy, sixty million people suffer from cerebrovascular diseases, three hundred and twenty-six million of the population suffer from migraines, and about 24 million people in the population have Alzheimer's disease and various other dementias, according to the California School of San Francisco. Globally, the Neurology Devices market was valued at USD 9.2 million in 2018. This value is expected to become USD 17.4 million by 2026.

Various statistics analyze that the European neurology market will have a CAGR of around 8.3% for the 2021-2028 timeline. The continued growth of various neurological disorders has increased the focus on medical device R&D, the adoption of various technological advances in healthcare, the increase in complications in the treatment of patients with recurrent stroke, and the increase in spending on the development of healthcare infrastructure, especially in developing economies. Major factors attributable to the growth of the Neuroscience 2023 market.

European country level analysis

The continent, Europe, is expected to continue to make considerable gains over the forecast period. This is due to the presence of modern and advanced healthcare technologies along with the increasing number of cases of Neuroscience 2023. Germany is said to emerge as the dominant country in Europe due to increased government funds for the development of healthcare infrastructure.

European neurology market countries also provide individual market impact factors and changes in domestic market regulation. Data points including production locations and volumes, consumption volumes, price trend analysis, raw material cost, import-export analysis and upstream and downstream value chain analysis are some of the key indicators used. to forecast the market analysis for the UK. The presence and availability of global brands and the challenges they face due to high or low competition from local and domestic brands and the impact of domestic trade routes and tariffs are considered for the calculation of France's Paris forecast analysis.

For each country, a detailed market analysis is provided. The country's growth includes healthcare spending for capital equipment, the impact of technology using lifeline curves, the installed base of different types of products, and changes in healthcare regulatory landscapes.

The European market for neurological biomarkers was US$1,221.15 million in 2019 and is expected to reach US$3,062.94 million in 2027. The estimated market growth CAGR is 12.4% during this period. The market is expected to witness steady growth due to the various driving factors including the increasing occurrence of neurological disorders and intense research on neurological biomarkers. However, complications associated with the use of neurological biomarkers are expected to hamper market growth of Neuroscience

Furthermore, the increased awareness of the benefits of early diagnosis is expected to provide growth opportunities to market participants for the development of new biomarkers, while in the market, patient inclination towards personalized/delivery solutions is expected. accuracy is a continuing trend. The increase in these neurological disorders is expected to drive the growth of the market in the coming years. Globally, in 2021, the Neurology services market was worth US$2,342.9 billion and is expected to expand 1.7 times over the next ten years. The neurology services market is expected to reach $4,317.8 billion by the end of 2032, with sales revenue set to register a CAGR of 5.4% from 2022 to 2032.

The main factors driving the growth of the market are the large investments made by private players in neurology devices, the increase in R&D in the field of Neuroscience and the increase in the aging of the population. The growth of the neurology devices market in the UK is also attributed to the increasing incidence of neurological disorders which include brain aneurysms, brain tumours, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, post-herpetic neuralgia, tumor of the spinal cord, and stroke. Furthermore, rising healthcare spending, rising investment by medical device manufacturers and rising prevalence of neurological diseases are expected to drive the overall growth of the neurology device market in France.

The WHO has stated that around 14% of individuals will suffer from some Neuroscience 2023.

European Neurological Disorder Drug Market Revenue by Region:

North America
Europe
China
Japan
Middle East & Africa
India
South America
Others.

Scientific Sessions

Track01: Neuroscience and Neurology

Neuroscience is currently recognized as one of the most dynamic areas of cell biology. All human functions are influenced by neuroscience, but it also leads to a better understanding of a wide variety of common conditions such as Down syndrome, autism spectrum disorder (ASD), ADHD, substance abuse, schizophrenia , Parkinson's disease, brain tumours, epilepsy, the effects of a stroke, eg loss of language, immune system disorders. A better understanding of neurological factors will help design drugs and other methods to treat and prevent these and many other health problems. Advances in science have allowed neuroscientists to study the structure, functions, development, abnormalities, and ways of modifying the nervous system.

Track 02: Psychiatry

For most psychiatric disorders, there are no laboratory tests to verify the condition. Instead, a patient undergoes a series of psychological tests, although biochemical tests are also done to see the physical health status of the patient. Psychiatrists use several types of treatment to manage psychological states, including psychotherapy, medications such as antipsychotics, mood stabilizers, and antidepressants. Psychotherapy may include cognitive behavior modification, group therapy, or group counseling. Hospitalization may also be necessary in severe cases. Psychiatry is one of the oldest branches of medicine but the sector has developed considerably since the arrival of neuroscience

Track03: Neuroimmunology

Neuroimmunology as a distinct field has its origins in the fields of neurology, psychiatry, and immunology. Although neuroimmunologists initially focused on classic neuroinflammatory disorders such as multiple sclerosis and infections, there is strong evidence that the immune response leads to inherited white matter disorders, epilepsy, neurodegenerative diseases , neuropsychiatric disorders, peripheral nervous system disorders and neuro-oncological disorders, as well as aging. Our understanding of how the immune system affects the nervous system during development and aging and how these responses lead to disease as well as regeneration and repair has been greatly aided by advances in technology.

Track04: Child and Adolescent Psychiatry

Child and adolescent psychiatry specializes in the diagnosis, treatment and prevention of mental disorders in children and adults. Child and adolescent psychiatry has the multidisciplinary channel disorder of emotion and behaviour that has its origins in neurophysiology, genetics, and environmental factors that affect child growth and development. The most common childhood mental disorders are anxiety disorders, depression and deficit hyperactivity disorder (ADHD). Normally, young people with mental disorders will have lower educational outcomes and greater involvement in the criminal justice system.

A variety of treatments are available to treat childhood mental disorders/mental illnesses, such as several effective medications, educational or vocational interventions, as well as specific types of psychotherapy, over the course of a year almost a quarter of young people and teenagers suffer from some kind of mental disorder.

Track05: Psychology and Mental Health

Neuropsychology combines elements of neurology and psychology. Neuropsychologists study the effects of psychological conditions on the nervous system, including the brain and spine, and they may also research ways in which altered brain chemistry due to injury, hormones, or environmental factors can affect mental health. Neuropsychology is primarily concerned with assessing conditions that affect brain health, such as Alzheimer's disease and traumatic brain injury, and assessing how neurological functioning can affect mental health. Clinical neuropsychologists perform psychometric assessments to measure neurological health. Neuropsychology has a strong experimental tradition. Many neuropsychologists use a trial and error approach, making small changes to test their effectiveness.

Track06: Paediatric Neurology

Just as pediatric neurology evolved as an identified specialty because the volume and complexity of knowledge became too great for the pediatrician or adult neurologist to master, the discipline has now continued to evolve into many subspecialties. , such as epilepsy, neuromuscular diseases, strokes. , malformations, neonatal neurology, metabolic diseases, etc., that the overall pediatric neurologist cannot reasonably possess in-depth expertise in all areas, especially in the management of complex cases. Sub-specialty expertise is therefore provided to some trainees through fellow programmers after a residency in general pediatric neurology and many of these fellowships include research training.

Track07: Adult Neurogenesis and Cell Biology

One of the best scientific discoveries of the 20th century is that the mammalian brain can produce new neurons throughout life. The phenomenon of adult neurogenesis raises hopes of harnessing neural somatic cells for brain repair and has sparked interest in novel roles for these new neurons, such as olfaction, spatial memory, and even the regulation of brain function. 'mood. Traditionally, studies of adult neurogenesis have combined with exogenous markers of DNA synthesis, such as bromodeoxyuridine (BrdU), to label and track the birth of late cells. However, the exponential increase in our knowledge of endogenous cell cycle markers has ushered in a new era of somatic cell biology.

Track08: Neuroinfections and Neuroinflammation

Neuroinflammation can be a complex inflammatory process within the central nervous system which is sought to play a crucial defensive role against various pathogens, toxins or factors that induce neurodegeneration. The occurrence of neurodegenerative diseases and various microbial infections are counted as stimuli that will challenge the host system and trigger the neuroinflammation event. The homeostatic nature of neuroinflammation is important in supporting neuroplasticity. Neuroinflammation is regulated by the activity of neuronal, glial and endothelial cells within the neurovascular unit, which is a “platform” for the coordinated action of pro- and anti-inflammatory mechanisms. The production of inflammatory mediators (cytokines, chemokines, reactive oxygen species) by resident brain cells or cells migrating from peripheral blood results in impaired barrier integrity, thus further affecting the evolution of the local inflammation.

Track09: Neuropharmacology and Neuroendocrinology

Neuroendocrine components activated by stressors include increased epinephrine and norepinephrine secretion from the sympathetic nervous system and spinal cord, discharge of corticotropin releasing factor (CRF) and vasopressin from neurons parvicellular in the portal circulation, and a few seconds later, the secretion of pituitary adrenocorticotropin (ACTH), leading to the secretion of glucocorticoids by the adrenal gland. Corticotropin-releasing factor coordinates endocrine, autonomic, behavioral, and immune responses to worry and also acts as a neurotransmitter or neuromodulator in the amygdala, dorsal raphe nucleus, hippocampus, and locus coeruleus, to integrate multisystem brain responses to worry.

Track10: Alzheimer Disease, Ageing and Dementia

Dementia can be a general term for a decline in ability severe enough to interfere with lifestyle. Alzheimer's disease is the most common explanation for dementia. Dementia is not a traditional part of aging. It is caused by damage to brain cells that affects their ability to speak, which can affect thinking, behavior and feelings. Aging and AD are related in the way, so it is reasonable to wonder whether or not it is possible to grow old without AD appearing inexorably at all times, given the lifespan. Alzheimer's disease is strongly linked to neurodegeneration and decreased cognition, including language skills, practice, memory loss with loss of ability to recognize faces and remember names, loss of judgment and emotional stability, personality alterations, progressive and increased loss of neurons with the presence of neuritic plaques, neurofibrillary tangles, generalized destruction of the neural network, brain and evident hippocampal atrophy; however, several factors are linked to normal aging.

Track11: Stroke and Trauma

With increased awareness of the intense impact of traumatic brain injury in recent years, a common question is whether or not traumatic brain injury can cause strokes. Many well-known athletes have spoken of traumatic brain injury and how it affected their lives years after quitting sports. Traumatic brain injury research has also found an association between traumatic brain injury and stroke. After trauma, strokes are common. Indeed, while recent concepts of stroke exclude pathologies directly related to trauma, there are still many mechanisms by which subsequent ischemia or hemorrhage may be caused by a prior traumatic event.

Track12: Neurosurgery

Neurosurgery is the medicine concerned with the diagnosis and treatment of patients with injuries or diseases/disorders of the brain, spinal cord and spine, and peripheral nerves in all parts of the body. The specialty of neurosurgical care includes adult and pediatric patients. Depending on the character of the injury or disease, a neurological surgeon may provide surgical and/or non-surgical care.

Track13: Brain and Neurological Disorders

Any disorder that occurs in the body's nervous system is called a neurological disorder. Brain, spinal cord, or other nerves such as structural, biochemical, or electrical abnormalities can sometimes lead to symptoms. Symptoms of the nerve disorder can also be loss of sensation, poor coordination, muscle weakness, paralysis, confusion, pain, and altered levels of consciousness. Biochemical changes and sometimes physical damage to the brain, spinal cord, or nerves are often caused by the nerve disorder. But in some cases, it is impossible to determine the root cause by only seeing the effects.

Track14: Neuroimaging and pathology

Neuroimaging has revolutionized all of clinical neuroscience, especially how gross brain pathology can be identified in the living patient. In traumatic brain injury (TBI), computerized tomography (CT) and magnetic resonance imaging (MRI) are the primary neuroimaging methods for pathological identification of acute and subacute traumatic injury, with MRI being best suited to identify and quantify more chronic lesions. effects. However, all neuroimaging findings of trauma-related pathology are only crude indicators of the underlying microscopic cellular and vascular pathologies that form the idea of â€‹â€‹all CBTs.

Track15: Neurotherapeutics, Diagnostics and Case studies

Researchers and doctors have used a variety of imaging techniques and chemicals to diagnose a nerve disorder. After diagnosis, many treatment techniques, including medications (topical, oral, and intravenous), device-based therapies (such as deep brain stimulation), surgery (such as tumor removal processes), physiotherapy and rehabilitation, show promising results for an efficient nervous system. treatment of disorders. Clinical skills, cutting-edge research and personalized attention are the essential requirements for providing in-depth care for a range of neuropsychological disorders and conditions. This conference can be a better platform to expand deeper experiences in procedures accepted in clinical trials, and drill into the difficulties of stroke and neurology and take a look at the most preclinical and clinical studies recent.

Track16: Neurological Complications of COVID_19

The COVID-19 pandemic, caused by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is on a scale not seen since the 1918 influenza pandemic; while the prevalent clinical diagnosis is that of respiratory disease, there is a growing awareness of neurological manifestations. Substantiated knowledge of other coronaviruses, especially those who caused severe acute respiratory syndrome and east-central respiratory syndrome outbreaks, cases of CNS and peripheral nervous system disease caused by SARS-CoV-2 should be considered rare. Neuroscience 2021 provides a platform for scientists, researchers and young scholars to outsmart the neurological complication of COVID-19.

Metrics

The Pulsus Group is one of the most outstanding scientific conference organizers in the world that have their individuality in all areas of science, technology and business. Part of the success of each lecture series depends specifically on how well it reaches the online community. Having an online audience is essential to making an international gathering a great success; whether they are research or academic or industrial.

Researchers, academicians, research institutes, industrialists and students in the field of plant sciences are the main participants who show a strong desire to attend the conference on agriculture offered by Pulsus conferences. Conferences based on Neuroscience and Psychiatry studies show a significantly high number of unique visitors and page views which have proven to be a thriving success.

Pulsus further extends its boundaries by maintaining all of its conferences in its respective conference web pages and official social media accounts. Thus, aspiring to the participation of the international scientific and industrial communities to come and experience the pack of conferences, debates, product exhibitions and alliances.

About Conference

With a grand success of Neuroscience 2022,

We welcome you all to attend the“2^nd International Conference on Neuroscience and Psychiatry (ICNP-2023)” scheduled during February, 09 -11, 2023 at Paris, France. The main theme of the conference is “Heal the world of Neuroscience and Psychiatry”. Join this intimate forum to create meaningful partnerships with 50+ Neuroscience experts. Translate key technological & mechanistic neuroscience advances into the clinic.

Our goal is to bring together worldwide distinguished academics in the field of Neuroscience and Psychiatry to exchange and share meaningful experiences of various treatment procedures for mental health, neurological disorders and stroke.

Neuroscience 2023 Mission: To provide the highest quality neuroscience and psychiatry education to learners and practitioners of all levels.

Neuroscience 2023 Vision: Through our inspiring international faculty, innovative programming, and vibrant interactions among all attendees, Neuroscience 2023 conference aspires to be the best neuroscience and psychiatry educational event in the world.

Regards

Ryan Matthew

Programming Committee | Neuroscience 2023

Conference Highlights:

Neuroscience and Neurology·Psychiatry
Neuroimmunology
Child and Adolescent Psychiatry
Psychology and Mental Health
Paediatric Neurology
Adult Neurogenesis and Cell Biology
Neuroinfections and Neuroinflammation
Neuropharmacology and Neuroendocrinology
Alzheimer Disease, Ageing and Dementia
Stroke and Trauma
Neurosurgery
Brain and Neurological Disorders
Neuroimaging and pathology
Neurotherapeutics, Diagnostics and Case studies
Neurological Complications of COVID_19

Target Audience :

Neurologists, Neurosurgeons, Neuroscientists, and Researchers
Neurology Faculty and Students
Doctors and Scientists
Universities, Associations, and Societies
Students and Research Scholars
Business Delegates
Product Manufacturer
Psychiatrists and Psychologists

CONFERENCE OPPORTUNITIES:

Exclusive Sessions and Panel discussions on latest innovations in Neuroscience and Psychiatry
Lectures by the active Investigators
Keynote forums by Renowned Speakers
Speaker Forum
Poster Sessions on latest Innovation in all the relevant Areas
Panel discussions and interactive sessions.
Open Innovation Challenges
Poster Sessions on every career stage
Young Research Forum
Post-Doctoral Career Development Session
B2B Meetings
Global Networking with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Excellent platform to showcase the latest products in neuroscience and affiliates

Neuroscience 2023 is Going Hybrid! This Conference will be a hybrid event (there will be both an in-person conference and a virtual conference) because some people may not be able to travel due to the pandemic or its economic impact. Making the congress more accessible helps us to achieve our mission to elaborate and advance the Neuroscience and Psychiatry, and to expand the contribution to Neuroscience and Psychiatry community by reaching a much larger audience all over the region.

We strongly believe that Neuroscience 2023 will be a huge success and exceed our expectations extremely.

We look forward to your active participation and to welcoming you and your families with a fresh "Moin" in Paris- the gateway to the world.